Combination PPARγ and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2

Nuclear hormone receptors, including RXR and PPARγ, represent novel therapeutic targets in melanoma. We have previously shown that the DRO subline of the amelanotic melanoma A375 responds to rexinoid and thiazolidinedione (TZD) treatment in vitro and in vivo. We performed microarray analysis of A375...

Descripción completa

Detalles Bibliográficos
Autores principales: Klopper, Joshua P., Sharma, Vibha, Bissonnette, Reid, Haugen, Bryan R.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763133/
https://www.ncbi.nlm.nih.gov/pubmed/19859558
http://dx.doi.org/10.1155/2010/729876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763133/
https://www.ncbi.nlm.nih.gov/pubmed/19859558
http://dx.doi.org/10.1155/2010/729876

Ejemplares similares